The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Guillain-Barré Syndrome Market Research Report 2024
Synopsis
Guillain-Barré Syndrome is a rapid-onset muscle weakness caused by the immune system damaging the peripheral nervous system.
The global Guillain-Barré Syndrome market was valued at US$ 435.7 million in 2023 and is anticipated to reach US$ 546.2 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
North American market for Guillain-Barré Syndrome is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Guillain-Barré Syndrome is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Guillain-Barré Syndrome in Hospital Pharmacies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Guillain-Barré Syndrome include Grifols, CSL Behring, Octapharma, Nihon Pharmaceutical, Akari Therapeutics, China Biologic Products Holdings, Biotest and Kedrion, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Guillain-Barré Syndrome, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Guillain-Barré Syndrome.
Report Scope
The Guillain-Barré Syndrome market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Guillain-Barré Syndrome market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Guillain-Barré Syndrome companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Grifols
CSL Behring
Octapharma
Nihon Pharmaceutical
Akari Therapeutics
China Biologic Products Holdings
Biotest
Kedrion
Segment by Type
Intravenous Immunoglobulin
Plasma Exchange
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Guillain-Barré Syndrome companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Guillain-Barré Syndrome is a rapid-onset muscle weakness caused by the immune system damaging the peripheral nervous system.
The global Guillain-Barré Syndrome market was valued at US$ 435.7 million in 2023 and is anticipated to reach US$ 546.2 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
North American market for Guillain-Barré Syndrome is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Guillain-Barré Syndrome is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Guillain-Barré Syndrome in Hospital Pharmacies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Guillain-Barré Syndrome include Grifols, CSL Behring, Octapharma, Nihon Pharmaceutical, Akari Therapeutics, China Biologic Products Holdings, Biotest and Kedrion, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Guillain-Barré Syndrome, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Guillain-Barré Syndrome.
Report Scope
The Guillain-Barré Syndrome market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Guillain-Barré Syndrome market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Guillain-Barré Syndrome companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Grifols
CSL Behring
Octapharma
Nihon Pharmaceutical
Akari Therapeutics
China Biologic Products Holdings
Biotest
Kedrion
Segment by Type
Intravenous Immunoglobulin
Plasma Exchange
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Guillain-Barré Syndrome companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Guillain-Barré Syndrome Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Intravenous Immunoglobulin
1.2.3 Plasma Exchange
1.2.4 Others
1.3 Market by Application
1.3.1 Global Guillain-Barré Syndrome Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Guillain-Barré Syndrome Market Perspective (2019-2030)
2.2 Guillain-Barré Syndrome Growth Trends by Region
2.2.1 Global Guillain-Barré Syndrome Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Guillain-Barré Syndrome Historic Market Size by Region (2019-2024)
2.2.3 Guillain-Barré Syndrome Forecasted Market Size by Region (2025-2030)
2.3 Guillain-Barré Syndrome Market Dynamics
2.3.1 Guillain-Barré Syndrome Industry Trends
2.3.2 Guillain-Barré Syndrome Market Drivers
2.3.3 Guillain-Barré Syndrome Market Challenges
2.3.4 Guillain-Barré Syndrome Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Guillain-Barré Syndrome Players by Revenue
3.1.1 Global Top Guillain-Barré Syndrome Players by Revenue (2019-2024)
3.1.2 Global Guillain-Barré Syndrome Revenue Market Share by Players (2019-2024)
3.2 Global Guillain-Barré Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Guillain-Barré Syndrome Revenue
3.4 Global Guillain-Barré Syndrome Market Concentration Ratio
3.4.1 Global Guillain-Barré Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Guillain-Barré Syndrome Revenue in 2023
3.5 Guillain-Barré Syndrome Key Players Head office and Area Served
3.6 Key Players Guillain-Barré Syndrome Product Solution and Service
3.7 Date of Enter into Guillain-Barré Syndrome Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Guillain-Barré Syndrome Breakdown Data by Type
4.1 Global Guillain-Barré Syndrome Historic Market Size by Type (2019-2024)
4.2 Global Guillain-Barré Syndrome Forecasted Market Size by Type (2025-2030)
5 Guillain-Barré Syndrome Breakdown Data by Application
5.1 Global Guillain-Barré Syndrome Historic Market Size by Application (2019-2024)
5.2 Global Guillain-Barré Syndrome Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Guillain-Barré Syndrome Market Size (2019-2030)
6.2 North America Guillain-Barré Syndrome Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Guillain-Barré Syndrome Market Size by Country (2019-2024)
6.4 North America Guillain-Barré Syndrome Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Guillain-Barré Syndrome Market Size (2019-2030)
7.2 Europe Guillain-Barré Syndrome Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Guillain-Barré Syndrome Market Size by Country (2019-2024)
7.4 Europe Guillain-Barré Syndrome Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Guillain-Barré Syndrome Market Size (2019-2030)
8.2 Asia-Pacific Guillain-Barré Syndrome Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Guillain-Barré Syndrome Market Size by Region (2019-2024)
8.4 Asia-Pacific Guillain-Barré Syndrome Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Guillain-Barré Syndrome Market Size (2019-2030)
9.2 Latin America Guillain-Barré Syndrome Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Guillain-Barré Syndrome Market Size by Country (2019-2024)
9.4 Latin America Guillain-Barré Syndrome Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Guillain-Barré Syndrome Market Size (2019-2030)
10.2 Middle East & Africa Guillain-Barré Syndrome Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Guillain-Barré Syndrome Market Size by Country (2019-2024)
10.4 Middle East & Africa Guillain-Barré Syndrome Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Grifols
11.1.1 Grifols Company Detail
11.1.2 Grifols Business Overview
11.1.3 Grifols Guillain-Barré Syndrome Introduction
11.1.4 Grifols Revenue in Guillain-Barré Syndrome Business (2019-2024)
11.1.5 Grifols Recent Development
11.2 CSL Behring
11.2.1 CSL Behring Company Detail
11.2.2 CSL Behring Business Overview
11.2.3 CSL Behring Guillain-Barré Syndrome Introduction
11.2.4 CSL Behring Revenue in Guillain-Barré Syndrome Business (2019-2024)
11.2.5 CSL Behring Recent Development
11.3 Octapharma
11.3.1 Octapharma Company Detail
11.3.2 Octapharma Business Overview
11.3.3 Octapharma Guillain-Barré Syndrome Introduction
11.3.4 Octapharma Revenue in Guillain-Barré Syndrome Business (2019-2024)
11.3.5 Octapharma Recent Development
11.4 Nihon Pharmaceutical
11.4.1 Nihon Pharmaceutical Company Detail
11.4.2 Nihon Pharmaceutical Business Overview
11.4.3 Nihon Pharmaceutical Guillain-Barré Syndrome Introduction
11.4.4 Nihon Pharmaceutical Revenue in Guillain-Barré Syndrome Business (2019-2024)
11.4.5 Nihon Pharmaceutical Recent Development
11.5 Akari Therapeutics
11.5.1 Akari Therapeutics Company Detail
11.5.2 Akari Therapeutics Business Overview
11.5.3 Akari Therapeutics Guillain-Barré Syndrome Introduction
11.5.4 Akari Therapeutics Revenue in Guillain-Barré Syndrome Business (2019-2024)
11.5.5 Akari Therapeutics Recent Development
11.6 China Biologic Products Holdings
11.6.1 China Biologic Products Holdings Company Detail
11.6.2 China Biologic Products Holdings Business Overview
11.6.3 China Biologic Products Holdings Guillain-Barré Syndrome Introduction
11.6.4 China Biologic Products Holdings Revenue in Guillain-Barré Syndrome Business (2019-2024)
11.6.5 China Biologic Products Holdings Recent Development
11.7 Biotest
11.7.1 Biotest Company Detail
11.7.2 Biotest Business Overview
11.7.3 Biotest Guillain-Barré Syndrome Introduction
11.7.4 Biotest Revenue in Guillain-Barré Syndrome Business (2019-2024)
11.7.5 Biotest Recent Development
11.8 Kedrion
11.8.1 Kedrion Company Detail
11.8.2 Kedrion Business Overview
11.8.3 Kedrion Guillain-Barré Syndrome Introduction
11.8.4 Kedrion Revenue in Guillain-Barré Syndrome Business (2019-2024)
11.8.5 Kedrion Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
